Clinical Trial Update: The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating biodistribution and dosimetry of 99mTc-Glycopeptide in patients with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 99mTc-Glycopeptide (Technetium-99m glycopeptide)

Snippet

Sponsor: SeeCure LLC | Conditions: Breast Cancer | Phase 1 | Status: UNKNOWN